Gastric/Esophageal/Gastroesophageal Junction (GEJ) Adenocarcinoma
1 clinical trials · Condition
◉ Watch Gastric/Esophageal/Gastroesophageal Junction (GEJ) Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| DBC-664 in Adult Patients With Solid Tumors (NCT07705035) | Duboce Biopharmaceuticals, Inc. | 2026-07-17 |
Track Gastric/Esophageal/Gastroesophageal Junction (GEJ) Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.